Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer

More efficient drug delivery system and formulation with less adverse effects are needed for the clinical application of broad-spectrum antineoplastic agent doxorubicin (DOX). Here we obtained outer-membrane vesicles (OMVs), a nano-sized proteoliposomes naturally released by Gram-negative bacteria,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuerban, Kudelaidi, Gao, Xiwen, Zhang, Hui, Liu, Jiayang, Dong, Mengxue, Wu, Lina, Ye, Ruihong, Feng, Meiqing, Ye, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488491/
https://www.ncbi.nlm.nih.gov/pubmed/32963948
http://dx.doi.org/10.1016/j.apsb.2020.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488491/
https://www.ncbi.nlm.nih.gov/pubmed/32963948
http://dx.doi.org/10.1016/j.apsb.2020.02.002

Ejemplares similares